“…LS100, and consortium C133; however, this mechanism is still unknown owing to the absence of information on the involved degrading enzymes/genes (Cote et al, 1986; He et al, 1992; Guan et al, 2009; Li et al, 2011; Ahad et al, 2017). Aerobic biotransformation processes of DON by targeting C3-OH, including oxidation and epimerization, which results in the formation of 3-keto-deoxynivalenol (3-keto-DON) by Agrobacterium-Rhizobium E3-39 or D107 (Shima et al, 1997; Fuchs et al, 2000; Wilson et al, 2017) and 3- epi -deoxynivalenol (3 - epi - DON) by Nocardioides WSN05-2, Devosia mutans 17-2-E-8, and Sphingomonas S3-4, respectively (Ikunaga et al, 2011; Hassan et al, 2016; He et al, 2016a,b), have also been reported. Furthermore, glycosylation, acetylation, hydration, and hydroxylation have been identified to be involved in the process, based on decreased toxicity of the final metabolites compared with that of DON (Poppenberger et al, 2003; He et al, 2015; Pierron et al, 2016; Springler et al, 2017).…”